+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peri-implantitis Market - Global Forecast 2026-2032- Product Image
Peri-implantitis Market - Global Forecast 2026-2032- Product Image
Sale

Peri-implantitis Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • July 2026
  • Region: Global
  • 360iResearch™
  • ID: 5205000
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Peri-implantitis Market is projected to reach USD 1.30 Billion in 2026. It is expected to continue growing at a CAGR of 6.50%, reaching USD 1.90 Billion by 2032.

Peri-implantitis is a biofilm-associated, inflammatory condition affecting the tissues around dental implants, characterized by peri-implant mucosal inflammation and progressive loss of supporting bone. As dental implant therapy expands globally, peri-implant disease management has become a critical priority for dental clinicians, periodontists, oral surgeons, implant manufacturers, academic researchers, and healthcare payers. The condition is closely linked to plaque accumulation, prior periodontal disease, smoking, diabetes, inadequate maintenance, excess cement, prosthetic design limitations, and patient-specific immune responses. Current clinical attention is focused on early diagnosis, risk-based prevention, non-surgical debridement, regenerative and resective surgical approaches, implant surface decontamination, and long-term supportive peri-implant care. The peri-implantitis landscape is increasingly shaped by the need for evidence-based protocols, standardized case definitions, improved diagnostic accuracy, and therapies that preserve implant function while reducing recurrence. For stakeholders across oral healthcare, the opportunity lies in integrating prevention, digital monitoring, minimally invasive treatment, and patient adherence strategies into routine implant care pathways.

Transformative Shifts in the Peri-implantitis Landscape

The peri-implantitis landscape is undergoing transformative shifts driven by evolving clinical consensus, digital dentistry adoption, and a stronger emphasis on prevention. Historically, treatment approaches varied widely because disease definitions, severity grading, and outcome measures were inconsistent across clinical studies. The adoption of more standardized diagnostic frameworks has improved comparability and clinical decision-making, particularly around bleeding on probing, probing depth changes, suppuration, radiographic bone loss, and baseline implant records. At the same time, dental practices are moving from episodic intervention toward structured implant maintenance programs that include risk assessment, professional biofilm control, occlusal evaluation, and patient education. Treatment innovation is also reshaping care delivery. Air-abrasive decontamination, laser-assisted protocols, ultrasonic and titanium-compatible instrumentation, antiseptic adjuncts, local antimicrobials, regenerative biomaterials, and guided bone regeneration techniques are being evaluated to improve clinical outcomes. However, published evidence continues to show that no single modality is universally effective, reinforcing the importance of case selection, defect morphology, implant surface characteristics, and operator expertise. The shift toward personalized peri-implantitis management is therefore becoming central to clinical success.

Cumulative Impact of Artificial Intelligence on Peri-implantitis Care

Artificial intelligence is beginning to influence peri-implantitis prevention, diagnosis, workflow optimization, and clinical decision support. In implant dentistry, AI-enabled image analysis is being explored to support detection of marginal bone level changes on radiographs and cone-beam computed tomography images, helping clinicians identify early peri-implant bone loss more consistently. Machine learning models can also assist in risk stratification by combining clinical variables such as smoking status, history of periodontitis, glycemic control, plaque scores, bleeding indicators, implant location, prosthetic design, and maintenance compliance. The cumulative impact of AI is most meaningful when it strengthens-not replaces-clinical judgment. AI-supported charting, radiographic comparison, automated recall prioritization, and patient communication tools can improve follow-up consistency, which is essential because peri-implantitis is often detected after clinically meaningful tissue destruction has already occurred. In research settings, AI can accelerate evidence synthesis, phenotype classification, and analysis of large clinical datasets. Still, implementation must address data quality, algorithm validation, regulatory expectations, interoperability, bias mitigation, and transparent clinical governance before AI can become a routine standard in peri-implant disease management.

Key Regional Insights for Peri-implantitis

Asia-Pacific is experiencing rising clinical attention to peri-implantitis as dental implant adoption increases across urban centers and as specialty periodontal and prosthodontic services expand. Japan, South Korea, China, India, and Australia are advancing digital implant workflows, but access to standardized maintenance programs varies substantially between metropolitan and rural settings. North America is characterized by strong integration of implant dentistry into private dental practice, broad use of radiographic monitoring, and growing emphasis on risk-based recall programs, particularly for patients with diabetes, smoking exposure, or a history of periodontitis. Latin America shows increasing demand for implant rehabilitation and aesthetic dentistry, with Brazil and Mexico serving as important clinical education and treatment hubs; however, affordability and continuity of follow-up remain important determinants of peri-implantitis outcomes. Europe benefits from mature periodontal research networks, structured clinical guidelines, and high awareness of implant maintenance, with strong emphasis on evidence-based diagnosis and supportive peri-implant therapy. The Middle East is seeing rapid development of advanced dental clinics, especially in high-income Gulf markets, where digital dentistry and specialist-led implant care are increasingly common. Across Africa, implant dentistry is expanding unevenly, with access concentrated in private urban clinics; workforce training, cost barriers, and preventive maintenance infrastructure are central issues affecting peri-implantitis management.

Key Group Insights for Peri-implantitis

ASEAN countries are seeing growing demand for dental implants through expanding middle-class access, dental tourism, and private clinic investment, making peri-implantitis prevention increasingly relevant as long-term implant maintenance becomes a differentiator in care quality. In the GCC, high investment in premium dental services, digital imaging, and specialist-led care supports advanced diagnosis and treatment, while lifestyle-related risk factors such as diabetes heighten the need for structured peri-implant monitoring. The European Union provides a strong regulatory and clinical environment for evidence-based implant dentistry, with increasing alignment around quality systems, continuing professional education, and patient safety standards. BRICS countries show diverse peri-implantitis dynamics: China and India are scaling implant access rapidly, Brazil has a strong oral healthcare and implant training ecosystem, Russia maintains demand for implant rehabilitation across major cities, and South Africa reflects a more concentrated private-sector implant base. G7 countries generally demonstrate higher availability of specialist periodontal care, digital workflows, and maintenance protocols, but they also face aging populations and rising chronic disease burdens that complicate implant outcomes. NATO member countries overlap significantly with advanced dental markets in North America and Europe, where clinical readiness, academic research, and regulatory maturity support broader adoption of peri-implantitis diagnostic and treatment protocols.

Key Country Insights for Peri-implantitis

The United States has a highly developed implant dentistry ecosystem, with peri-implantitis management increasingly tied to periodontal risk assessment, radiographic surveillance, and maintenance compliance. Canada shows strong clinical awareness and preventive care standards, though access can vary by province and insurance coverage. Mexico combines domestic implant demand with cross-border dental care, making continuity of maintenance an important consideration. Brazil has one of the most active implant dentistry environments in Latin America, supported by specialist education and broad clinical experience, while patient adherence to long-term maintenance remains essential. The United Kingdom emphasizes evidence-based dental care and guideline-driven periodontal management, with peri-implant disease increasingly incorporated into specialist referral pathways. Germany, France, Italy, and Spain all demonstrate mature implant markets with strong professional education, digital dentistry adoption, and growing attention to supportive peri-implant therapy. Russia has significant urban demand for implant rehabilitation, with advanced care concentrated in major dental centers. China is rapidly expanding implant access through urban dental networks and digital technology adoption, creating a growing need for standardized peri-implantitis diagnosis and maintenance. India is experiencing increasing implant uptake in private practices, but variability in follow-up systems influences disease prevention. Japan faces an aging population with high restorative needs, making peri-implant health monitoring particularly important. Australia shows strong alignment with preventive dentistry and specialist periodontal care, while South Korea combines advanced digital dentistry, high clinical sophistication, and strong patient demand for implant-supported rehabilitation.

Actionable Recommendations for Peri-implantitis Industry Leaders

Industry leaders should prioritize prevention-first peri-implant care models that begin before implant placement and continue throughout the implant lifecycle. Dental professionals and solution providers should support standardized risk assessment covering periodontal history, smoking, diabetes control, plaque control, occlusion, keratinized mucosa, implant position, and prosthetic cleanability. Clinical teams should document baseline probing depths and radiographs after prosthesis delivery to improve future diagnosis. Education programs must reinforce that peri-implant mucositis is reversible when addressed early, while peri-implantitis requires more complex intervention and long-term maintenance. Manufacturers and clinical innovators should focus on implant and prosthetic designs that improve hygiene access, reduce plaque-retentive features, and support retrievability when maintenance or repair is needed. Digital platforms should be used to improve recall adherence, radiographic comparison, patient reminders, and outcome tracking. Treatment providers should adopt evidence-based, defect-specific protocols rather than relying on a single device or adjunctive therapy. Research leaders should invest in robust comparative clinical studies with standardized definitions, patient-reported outcomes, and long-term follow-up to strengthen clinical confidence in peri-implantitis interventions.

Research Methodology

This executive summary is based on a structured review of verified clinical, regulatory, academic, and public health sources related to peri-implantitis, peri-implant mucositis, dental implant maintenance, periodontal risk factors, diagnostic criteria, and treatment approaches. The methodology emphasizes evidence from peer-reviewed dental and periodontal literature, consensus workshop outputs, clinical practice guidelines, systematic reviews, and recognized public health and professional education resources. Insights were synthesized qualitatively to identify disease drivers, care pathway shifts, regional practice patterns, technology adoption trends, and evidence gaps. Regional, group, and country insights were developed by assessing oral healthcare infrastructure, implant dentistry adoption, specialist availability, digital dentistry maturity, chronic disease relevance, affordability considerations, and continuity of care challenges. The analysis intentionally excludes market sizing, revenue estimation, share calculation, and forecasting. The resulting perspective is designed to support strategic decision-making for stakeholders seeking to improve peri-implantitis prevention, diagnosis, treatment standardization, and long-term implant success.

Conclusion

Peri-implantitis is increasingly recognized as a major clinical challenge in modern implant dentistry, requiring coordinated action across prevention, diagnostics, treatment innovation, and patient maintenance. The most effective strategies are likely to combine standardized assessment, early identification of peri-implant mucositis, individualized risk management, and defect-specific therapy supported by consistent follow-up. Digital dentistry and artificial intelligence can improve monitoring and workflow efficiency, but their value depends on validated tools, high-quality data, and responsible clinical integration. Regional differences in access, training, reimbursement, and maintenance infrastructure will continue to influence outcomes, making localized strategies essential. For industry leaders, the path forward is clear: strengthen prevention, design for maintainability, support clinician education, generate higher-quality evidence, and empower patients to participate in lifelong implant care. By aligning innovation with evidence-based peri-implant health management, the dental ecosystem can reduce complications, preserve implant function, and improve long-term patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Peri-implantitis Market, by Product Type
7.1. Introduction
7.2. Adjunctive Devices
7.3. Laser Treatment
7.4. Pharmacological Treatment
7.5. Surgical Treatment
7.5.1. Graft Type
7.5.1.1. Allograft
7.5.1.2. Autograft
7.5.1.3. Synthetic
7.5.1.4. Xenograft
7.5.2. Membrane Type
7.5.2.1. Non-Resorbable
7.5.2.2. Resorbable
8. Peri-implantitis Market, by Treatment Modality
8.1. Introduction
8.2. Non Surgical
8.2.1. Local Antibiotic Therapy
8.2.2. Mechanical Debridement
8.3. Surgical
8.3.1. Regenerative Procedures
8.3.2. Resective Procedures
9. Peri-implantitis Market, by Implant Material
9.1. Introduction
9.2. Titanium
9.3. Zirconia
10. Peri-implantitis Market, by Severity
10.1. Introduction
10.2. Mild
10.3. Moderate
10.4. Severe
11. Peri-implantitis Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.3. Dental Clinics
11.4. Hospitals
12. Peri-implantitis Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Peri-implantitis Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Peri-implantitis Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Peri-implantitis Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. BEGO GmbH & Co. KG
17.2. Botiss biomaterials GmbH
17.3. Dentium Co., Ltd.
17.4. Dentsply Sirona Inc.
17.5. Freiburger Medizintechnik GmbH
17.6. GalvoSurge Dental AG
17.7. GC Corporation
17.8. Geistlich Pharma AG
17.9. Henry Schein, Inc.
17.10. Institut Straumann AG
17.11. Megagen Implant Co., Ltd.
17.12. Nobel Biocare Services AG
17.13. Southern Implants (Pty) Ltd
17.14. W&H Dentalwerk Bürmoos GmbH
17.15. ZimVie Inc.
List of Figures
FIGURE 1. GLOBAL PERI-IMPLANTITIS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PERI-IMPLANTITIS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PERI-IMPLANTITIS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PERI-IMPLANTITIS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PERI-IMPLANTITIS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ADJUNCTIVE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ADJUNCTIVE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ADJUNCTIVE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL LASER TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL LASER TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL LASER TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PHARMACOLOGICAL TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PHARMACOLOGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL SURGICAL TREATMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL SURGICAL TREATMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL SURGICAL TREATMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GRAFT TYPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GRAFT TYPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GRAFT TYPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ALLOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ALLOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ALLOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL AUTOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL AUTOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL AUTOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL XENOGRAFT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL XENOGRAFT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL XENOGRAFT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL MEMBRANE TYPE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL MEMBRANE TYPE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL MEMBRANE TYPE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL NON-RESORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL NON-RESORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL NON-RESORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL RESORBABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL RESORBABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL RESORBABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL NON SURGICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL NON SURGICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NON SURGICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL LOCAL ANTIBIOTIC THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL LOCAL ANTIBIOTIC THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL LOCAL ANTIBIOTIC THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL MECHANICAL DEBRIDEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL MECHANICAL DEBRIDEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL MECHANICAL DEBRIDEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL SURGICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL SURGICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL SURGICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL REGENERATIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL REGENERATIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL REGENERATIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL RESECTIVE PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL RESECTIVE PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL RESECTIVE PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL TITANIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL TITANIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL TITANIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ZIRCONIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ZIRCONIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ZIRCONIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL MILD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL MILD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL MILD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL MODERATE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL MODERATE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL MODERATE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL SEVERE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL SEVERE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL SEVERE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL AMBULATORY SURGERY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DENTAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DENTAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DENTAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 121. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 130. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 133. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 134. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 135. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 136. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 137. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 138. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 139. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 140. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 150. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 151. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 152. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 157. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 158. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 159. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 160. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 161. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 162. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 163. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 164. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 165. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 169. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 170. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 171. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 172. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 173. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 174. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 175. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 176. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 177. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. GCC PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GCC PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 181. GCC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 182. GCC PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 183. GCC PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 184. GCC PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 185. GCC PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 186. GCC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 187. GCC PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 188. GCC PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 189. GCC PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 190. GCC PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 201. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. BRICS PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. BRICS PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 206. BRICS PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 207. BRICS PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 208. BRICS PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 209. BRICS PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 210. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 211. BRICS PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 212. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 213. BRICS PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. BRICS PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 215. G7 PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 216. G7 PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 217. G7 PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 218. G7 PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 219. G7 PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 220. G7 PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 221. G7 PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 222. G7 PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 223. G7 PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 224. G7 PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 225. G7 PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. G7 PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 227. NATO PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 228. NATO PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 229. NATO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 230. NATO PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 231. NATO PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 232. NATO PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 233. NATO PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 234. NATO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 235. NATO PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 236. NATO PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 237. NATO PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. NATO PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 242. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 243. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 244. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 245. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 246. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 247. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 248. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 249. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 250. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. CANADA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 253. CANADA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 254. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 255. CANADA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 256. CANADA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 257. CANADA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 258. CANADA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 259. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 260. CANADA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 261. CANADA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 262. CANADA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 263. CANADA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 264. MEXICO PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 265. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 266. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 267. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 268. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 269. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 270. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 271. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 272. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 273. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 274. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. MEXICO PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 276. BRAZIL PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 277. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 278. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 279. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 280. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 281. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 282. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 283. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 284. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 285. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 286. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. BRAZIL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 288. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 289. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 292. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 293. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 294. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 295. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 296. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 297. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 298. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. UNITED KINGDOM PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 300. GERMANY PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 301. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 302. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 303. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 304. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 305. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 306. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 307. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 308. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 309. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 310. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 311. GERMANY PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 312. FRANCE PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 313. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 314. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 315. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 316. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 317. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 318. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 319. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 320. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 321. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 322. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 323. FRANCE PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 324. RUSSIA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 325. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 326. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 327. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 328. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 329. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 330. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 331. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 332. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 333. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 334. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 335. RUSSIA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 336. ITALY PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 337. ITALY PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 338. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 339. ITALY PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 340. ITALY PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 341. ITALY PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 342. ITALY PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 343. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 344. ITALY PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 345. ITALY PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 346. ITALY PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 347. ITALY PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 348. SPAIN PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 349. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 350. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 351. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 352. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 353. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 354. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 355. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 356. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 357. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 358. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 359. SPAIN PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 360. CHINA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 361. CHINA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 362. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 363. CHINA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 364. CHINA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 365. CHINA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 366. CHINA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 367. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 368. CHINA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 369. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 370. CHINA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 371. CHINA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 372. INDIA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 373. INDIA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 374. INDIA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLIO

Companies Mentioned

  • BEGO GmbH & Co. KG
  • Botiss biomaterials GmbH
  • Dentium Co., Ltd.
  • Dentsply Sirona Inc.
  • Freiburger Medizintechnik GmbH
  • GalvoSurge Dental AG
  • GC Corporation
  • Geistlich Pharma AG
  • Henry Schein, Inc.
  • Institut Straumann AG
  • Megagen Implant Co., Ltd.
  • Nobel Biocare Services AG
  • Southern Implants (Pty) Ltd
  • W&H Dentalwerk Bürmoos GmbH
  • ZimVie Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedJuly 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.3 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.9 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Peri-Implantitis - Global Strategic Business Report - Product Image

Peri-Implantitis - Global Strategic Business Report

  • Report
  • 267 Pages
  • Global
From
Peri-implantitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Peri-implantitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
Periodontal Dental Services Market - Global Forecast 2026-2032 - Product Image

Periodontal Dental Services Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Dental Air Polishing Unit Market - Global Forecast 2026-2032 - Product Image

Dental Air Polishing Unit Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Dental Implant Sand Blaster Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Dental Implant Sand Blaster Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.